Human monoclonal antibodies against amyloid-beta from healthy adults

Neurobiology of Aging

Volumn 26, Issue 5, 2005, Pages 597-606

  Geylis, Valeria ^a   Kourilov, Vitaly ^a   Meiner, Zeev ^b   Nennesmo, Inger ^c   Bogdanovic, Nenad ^d   Steinitz, Michael ^a  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer's disease; Anti amyloid beta antibodies; Epstein Barr virus; Human monoclonal antibodies; Immunotherapy; Passive immunization

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-16]; MONOCLONAL ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIBODY AFFINITY; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FROZEN SECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; LYMPHOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENILE PLAQUE; STAINING; WESTERN BLOTTING;

EID: 13644249899     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2004.06.008     Document Type: Article

References (47)

1. H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, and M. Greg Inflammation and Alzheimer's disease Neurobiol Aging 21 2000 383 421
2. S. Avrameas Natural autoantibodies: from horror autotoxicus to gnothi seauton Immunol Today 12 1991 154 159
3. B.J. Backskai, S.T. Kajdasz, R.H. Christie, C. Carter, D. Games, and P. Seubert Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy Nat Med 7 2001 369 372
4. F. Bard, C. Cannon, R. Barbour, R.L. Burke, D. Games, and H. Grajeda Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease Nat Med 6 2000 916 919
5. F. Bard, R. Barbour, C. Cannon, R. Carretto, M. Fox, and D. Games Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology Proc Natl Acad Sci USA 100 2003 2023 2028
6. N. Bogdanovic, and J.C. Morris Diagnostic criteria for Alzheimer's disease in Multi-centre Brain Banking F.F. Cruz-Sanchez Biomedical and Health Research Series 1995 IOS press Amsterdam 20 29
7. G. Chen, K.S. Chen, J. Knox, J. Inglis, A. Bernard, and S.J. Martin A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease Nature 408 2000 975 979
8. R.B. DeMattos, K.R. Bales, D.J. Cummins, J.C. Dodart, S.M. Paul, and D.M. Holtzman Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease Proc Natl Acad Sci USA 98 2001 8850 8855
9. R.B. DeMattos, K.R. Bales, D.J. Cummins, S.M. Paul, and D.M. Holtzman Brain to plasma amyloid-β efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease Science 295 2002 2264 2267
10. R. Dodel, H. Hampel, C. Depboylu, S. Lin, F. Gao, and S. Schock Human antibodies against amyloid β peptide: A potential treatment for Alzheimer's disease Ann Neurol 52 2002 253 256
11. Y. Du, R. Dodel, H. Hampel, K. Buerger, S. Lin, and B. Eastwood Reduced levels of amyloid β-peptide antibody in Alzheimer disease Neurology 57 2001 801 805
12. Y. Du, X. Wei, R. Dodel, N. Sommer, H. Hampel, and F. Gao Human anti-β-amyloid antibodies block β-amyloid fibril formation and prevent β-amyloid-induced neurotoxicity Brain 126 2003 1935 1939
13. H. Eastwood, and K.R. Cole Staining of amyloid by buffered Congo red in 50 per cent ethanol Stain Technol 46 1971 208 209
14. L gene usage by anti-β-amyloid autoantibodies in Alzheimers-disease: detection of highly mutated V-regions in both heavy and light chains Clin Immunol Immunopathol 75 1995 159 167
15. D. Frenkel, B. Solomon, and I. Benhar Modulation of Alzheimer's β-amyloid neurotoxicity by site-directed single-chain antibody J Neuroimmunol 106 2000 23 31
16. C. Geula, C.K. Wu, D. Saroff, A. Lorenzo, M. Yuan, and B.A. Yankner Aging renders the brain vulnerable to amyloid β-protein neurotoxicity Nat Med 4 1998 827 831
17. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics Science 297 2002 353 356
18. C. Hock, U. Konietzko, A. Papassotiropoulos, A. Wollmer, J. Steffer, and R.C. von Rotz Generation of antibodies specific for β-amyloid by vaccination of patients with Alzheimer disease Nat Med 8 2002 1270 1275
19. C. Hock, U. Konietzko, J.R. Steffer, J. Tracy, A. Signorell, and B. Muller-Tillmanns Antibodies against β-amyloid slow cognitive decline in Alzheimer's disease Neuron 38 2003 547 554
20. C. Janus, J. Pearson, J. McLaurin, P.M. Mathews, Y. Jiang, and S.D. Schmidt Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease Nature 408 2000 979 982
21. K. Johnson-Wood, M. Lee, R. Motter, K. Hu, G. Gordon, and R. Barbour Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease Proc Natl Acad Sci USA 94 1997 1550 1555
22. V. Kourilov, and M. Steinitz Magnetic-bead enzyme-linked immunosorbent assay verifies adsorption of ligand and epitope accessibility Anal Biochem 311 2002 166 170
23. V. Lechtzier, M. Hutoran, T. Levy, M. Kotler, T. Brenner, and M. Steinitz Sodium dodecyl sulphate-treated proteins as ligands in ELISA J Immunol Methods 270 2002 19 26
24. P.L. McGeer, and E.G. McGeer Local neuroinflammation and the progression of Alzheimer's disease J Neurovirol 8 2002 529 538
25. D. Morgan, D.M. Diamond, P.E. Gottschall, K.E. Ugen, C. Dickey, and J. Hardy Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease Nature 408 2000 982 985
26. J.A.R. Nicoll, D. Wilkinson, C. Holmes, P. Steart, H. Markham, and R.O. Weller Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report Nat Med 9 2003 448 452
27. B. O'Nuallain, and R. Wetzel Conformational Abs recognizing a generic amyloid fibril epitope Proc Natl Acad Sci USA 99 2002 1485 1490
28. D. Schenk, R. Barbour, W. Dunn, G. Gordon, H. Grajeda, and T. Guido Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 1999 173 177
29. D. Schenk Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning Nat Rev Neurosci 3 2002 824 828
30. D. Scheuner, C. Eckman, M. Jensen, X. Song, M. Citron, and N. Suzuki Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease Nat Med 2 1996 864 870
31. K. Senior Dosing in phase II trial of Alzheimer's vaccine suspended Lancet Neurol 1 2002 1 3
32. E.M. Sigurdsson, H. Scholtzova, P.D. Mehta, B. Frangione, and T. Wisniewski Immunization with a nontoxic/nonfibrillar amyloid-β homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice Am J Path 159 2001 439 447
33. B. Solomon, R. Koppel, E. Hanan, and T. Katzav Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer β-amyloid peptide Proc Natl Acad Sci USA 93 1996 452 455
34. B. Solomon, R. Koppel, D. Frankel, and E. Hanan-Aharon Disaggregation of Alzheimer β-amyloid by site-directed mAb Proc Natl Acad Sci USA 94 1997 4109 4112
35. M. Steinitz, G. Klein, S. Koskimies, and O. Makela EB virus-induced B lymphocyte cell lines producing specific antibody Nature 269 1977 420 422
36. M. Steinitz, G. Izak, S. Cohen, M. Ehrenfeld, and I. Flechner Continuous production of monoclonal rheumatoid factor by EBV-transformed lymphocytes Nature 287 1980 443 445
37. S. Steinitz, and S. Tamir Human monoclonal antibodies produced by Epstein-Barr virus transformed cell lines bind protein A Immunol Lett 9 1985 19 22
38. M. Steinitz Human monoclonal antibodies produced by Epstein Barr virus immortalized cell lines: technical and theoretical principles R.S. Pal Immunoassay technology 1988 Macmillan Press UK 1 17
39. M. Steinitz, S. Tamir, J.E. Frodin, A.K. Lefvert, and H. Mellstedt Human monoclonal anti-idiotypic antibodies I. Establishment of immortalized cell lines from a tumor patient treated with mouse monoclonal antibodies J Immunol 141 1988 3516 3522
40. M. Steinitz, and L. Baraz A rapid method for estimating the binding of ligands to ELISA microwells J Immunol Methods 238 2000 143 150
41. K.M. Thompson, D.W. Hough, P.J. Maddison, M.D. Melamed, and N. Hughes-Jones The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner J Immunol Methods 94 1986 7 12
42. L.O. Tjernberg, D.J.E. Callaway, A. Tjernberg, S. Hahne, C. Lilliehook, and L. Terenius A molecular model of Alzheimer amyloid β-peptide fibril formation J Biol Chem 274 1999 12619 12625
43. H. Towbin, T. Staehelin, and J. Gordon Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets - procedure and some applications Proc Natl Acad Sci USA 76 1979 4350 4354
44. M.E. Weksler, N. Relkin, R. Turkenich, S. LaRusse, L. Zhou, and P. Szabo Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individuals Exp Gerontol 37 2002 943 948
45. S. Xu, and F. Gaskin Increased incidence of anti-β-amyloid autoantibodies secreted by Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease Mech Ageing Dev 94 1997 213 222
46. B.A. Yankner Mechanisms of neuronal degeneration in Alzheimer's disease Neuron 16 1996 921 932
47. S.G. Younkin Amyloid β vaccination: reduced plaques and improved cognition Nat Med 7 2001 18 19